Status:
UNKNOWN
Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension
Lead Sponsor:
Eastern Virginia Medical School
Collaborating Sponsors:
AMAG Pharmaceuticals, Inc.
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
In 2017, the American College of Cardiology and the American Heart Association changed the diagnostic criteria for hypertension in non-pregnant adults. The parameters for the diagnosis of stage 1 hype...
Detailed Description
In 2017, the American College of Cardiology (ACC) and the American Heart Association (AHA) changed the diagnostic criteria for hypertension in non-pregnant adults.1 The parameters for the diagnosis of...
Eligibility Criteria
Inclusion
- Pregnant women from 6 0/7 to 13 6/7 weeks gestation
- 18-50 years old
- Systolic blood pressure of 130-139 mmHg or Diastolic blood pressure of 80-89 mmHg
Exclusion
- History of preeclampsia
- Multifetal gestation
- Chronic hypertension
- Pre-gestational diabetes
- Renal disease
- Autoimmune disease
- Aspirin allergy or hypersensitivity
- Presence of nasal polyps
- History of aspirin-induced bronchospasm
Key Trial Info
Start Date :
May 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04908982
Start Date
May 28 2021
End Date
May 31 2023
Last Update
June 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School
Norfolk, Virginia, United States, 23507